Category Archives: Hepatitis C care & treatment

CROI 2017: New two-drug maintenance regimen continues to suppress HIV over 144 weeks

At the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), results from the LATTE study showed that the 2-drug regimen of the integrase inhibitor cabotegravir (CAB) + the NNRTI rilpirivine (RPV, Edurant) suppressed HIV levels as well as a 3-drug efavirenz (Sustiva) regimen through 144 weeks….Read More

CROI 2017: Ibalizumab is effective at reducing HIV viral load in people with few treatment options

In a late-breaker presentation at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), a new monoclonal antibody drug called ibalizumab reduced viral loads in individuals with multi-drug resistant HIV. The results showed that adding the drug to a failing regimen may help treatment-experienced people who…Read More

Statement from Covered California’s Peter V. Lee on the House Passage of the American Health Care Act

SACRAMENTO, CA. — Covered California Executive Director Peter V. Lee released the following statement on the passing of the American Health Care Act by the U.S. House of Representatives: “Today the House of Representatives took a significant step toward making what could be monumental changes to…Read More

Project Inform releases new baby boomer videos on hepatitis C treatment

At least 3.5 million Americans are living with HCV, though it’s likely that there are many more. Approximately three-fourths of this group were born between 1945 and 1965 — the baby boomer generation. Since hepatitis C disease usually has no symptoms early on, about half of those…Read More

LGBT and PLWH have disproportionately benefitted from the ACA

LGBT people and people living with HIV have disproportionately benefitted from the expansion of health insurance coverage under the Affordable Care Act. This is also true of Black and Latino Americans. LGBT people and PLWH have much at stake in the debate currently taking place in…Read More

Takeaways from the 2016 Liver Meeting for Viral Hepatitis Advocates

The American Association for the Study of Liver Diseases (AASLD) held its annual conference, The Liver Meeting, from November 11-15 in Boston. Traditionally, the Liver Meeting attendees are clinicians and researchers and the program is primarily filled with highly technical scientific content. As a public health…Read More

Project Inform leads effort to improve HIV care retention and re-linkage

Project Inform has long hosted Think Tanks that bring together the community with other key stakeholders, including researchers, government officials and health care providers to tackle specific issues that others haven’t fully explored. On December 13 and 14, 2016, we hosted a meeting designed to address…Read More